Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.
Grillo E, Ravelli C, Corsini M, Ballmer-Hofer K, Zammataro L, Oreste P, Zoppetti G, Tobia C, Ronca R, Presta M, Mitola S.
Grillo E, et al. Among authors: ravelli c.
Oncotarget. 2016 Jun 7;7(23):35353-68. doi: 10.18632/oncotarget.9286.
Oncotarget. 2016.
PMID: 27174917
Free PMC article.